Ingevity Corporation $NGVT Holdings Raised by Pacer Advisors Inc.

Pacer Advisors Inc. boosted its stake in Ingevity Corporation (NYSE:NGVT) by 4.5% in the first quarter, Holdings Channel reports. The institutional investor owned 170,543 shares of the company’s stock after acquiring an additional 7,315 shares during the quarter. Pacer Advisors Inc.’s holdings in Ingevity were worth $12,148,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Edgestream Partners L.P. grew its holdings in shares of Ingevity by 11.3% during the 1st quarter. Edgestream Partners L.P. now owns 100,487 shares of the company’s stock valued at $7,158,000 after acquiring an additional 10,169 shares in the last quarter. Amundi raised its holdings in shares of Ingevity by 116.0% during the first quarter. Amundi now owns 9,389 shares of the company’s stock worth $669,000 after acquiring an additional 5,042 shares in the last quarter. California State Teachers Retirement System raised its holdings in shares of Ingevity by 16.8% during the first quarter. California State Teachers Retirement System now owns 40,537 shares of the company’s stock worth $2,887,000 after acquiring an additional 5,828 shares in the last quarter. Empowered Funds LLC purchased a new stake in shares of Ingevity during the first quarter worth $373,000. Finally, Quantinno Capital Management LP boosted its position in Ingevity by 21.6% during the first quarter. Quantinno Capital Management LP now owns 17,635 shares of the company’s stock valued at $1,256,000 after purchasing an additional 3,132 shares during the last quarter. Institutional investors and hedge funds own 91.59% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on NGVT. Weiss Ratings upgraded Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Friday. Wall Street Zen downgraded Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $80.00.

Insiders Place Their Bets

In related news, SVP Ryan C. Fisher sold 2,709 shares of the company’s stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $73.72, for a total value of $199,707.48. Following the completion of the sale, the senior vice president directly owned 15,722 shares in the company, valued at approximately $1,159,025.84. This represents a 14.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total transaction of $33,971.04. Following the transaction, the senior vice president directly owned 7,202 shares in the company, valued at $493,264.98. The trade was a 6.44% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.88% of the company’s stock.

Ingevity Price Performance

NYSE NGVT opened at $75.47 on Wednesday. The company has a quick ratio of 1.15, a current ratio of 1.61 and a debt-to-equity ratio of 22.52. The stock has a market capitalization of $2.59 billion, a PE ratio of 51.34 and a beta of 1.16. Ingevity Corporation has a 12-month low of $45.66 and a 12-month high of $79.29. The company has a 50 day moving average price of $72.03 and a two-hundred day moving average price of $71.13.

Ingevity (NYSE:NGVT) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, topping the consensus estimate of $1.33 by $0.41. The company had revenue of $314.10 million for the quarter, compared to analyst estimates of $312.20 million. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, equities analysts predict that Ingevity Corporation will post 5.4 earnings per share for the current fiscal year.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.